THAMAR ADAMS: Open Payments
NPI 1619631710 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,958 in 110 payments from 21 companies in 2025. Trend: 2023 $2,167 · 2024 $2,547 · 2025 $1,958
Food & beverage: $1,958
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $630 |
| GlaxoSmithKline, LLC. | 25 | $294 |
| HARMONY BIOSCIENCES LLC | 12 | $158 |
| GENZYME CORPORATION | 10 | $137 |
| Insmed, Inc. | 5 | $90 |
| Philips North America LLC | 4 | $78 |
| Verona Pharma, Inc. | 4 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $72 |
| Regeneron Healthcare Solutions, Inc. | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $47 |
Products named: AIRSUPRA, FASENRA, NUCALA, DUPIXENT, WAKIX, Arikayce, Vest Therapy Und, Ohtuvayre.
Industry payments across NJ — which companies pay providers there.
